112 related articles for article (PubMed ID: 9750023)
1. Tumour-proliferative fraction and growth factor expression as markers of tumour response to radiotherapy in cancer of the uterine cervix.
Pillai MR; Jayaprakash PG; Nair MK
J Cancer Res Clin Oncol; 1998; 124(8):456-61. PubMed ID: 9750023
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content.
Artagaveytia N; Le Penven S; Falette N; Lucero R; Garófalo EG; Saez S
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):221-8. PubMed ID: 9191980
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
Umekita Y; Ohi Y; Sagara Y; Yoshida H
Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
Hofmockel G; Riess S; Bassukas ID; Dämmrich J
Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
Glynne-Jones E; Goddard L; Harper ME
Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313
[TBL] [Abstract][Full Text] [Related]
9. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
[TBL] [Abstract][Full Text] [Related]
10. Absence of epidermal growth factor receptor expression in squamous cell carcinoma of the uterine cervix is an indicator of limited tumor disease.
Biesterfeld S; Schuh S; Muys L; Rath W; Mittermayer C; Schröder W
Oncol Rep; 1999; 6(1):205-9. PubMed ID: 9864429
[TBL] [Abstract][Full Text] [Related]
11. Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer.
Harima Y; Harima K; Shikata N; Oka A; Ohnishi T; Tanaka Y
J Cancer Res Clin Oncol; 1998; 124(9):503-10. PubMed ID: 9808425
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical studies on epidermal growth factor receptor in oncogenesis of uterine cervical cancer].
Ueda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1401-8. PubMed ID: 2685140
[TBL] [Abstract][Full Text] [Related]
13. bcl-2 immunoreactivity but not p53 accumulation associated with tumour response to radiotherapy in cervical carcinoma.
Pillai MR; Jayaprakash PG; Nair MK
J Cancer Res Clin Oncol; 1999; 125(1):55-60. PubMed ID: 10037278
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of nucleolar organizer region, proliferating cell nuclear antigen and epidermal growth factor receptor staining in colon tumours.
Shimada N; Suzuki J; Fujita J; Kawakami Y; Tsukakoshi H; Hosokawa M; Sato N
J Gastroenterol Hepatol; 1998 Aug; 13(8):794-800. PubMed ID: 9736172
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of epidermal growth factor-receptors (EGF-R) by nicotine in cervical cancer cell lines: this effect may be mediated by EGF.
Mathur RS; Mathur SP; Young RC
Am J Reprod Immunol; 2000 Aug; 44(2):114-20. PubMed ID: 10994639
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor-induced protection of tumour cell susceptibility to cytolysis.
Nouri AM; Hussain RF; Oliver RT
Eur J Cancer; 1995 Jun; 31A(6):963-9. PubMed ID: 7544146
[TBL] [Abstract][Full Text] [Related]
18. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
[TBL] [Abstract][Full Text] [Related]
19. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
Türkeri LN; Erton ML; Cevik I; Akdaş A
Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
